Top 25 Companies in Global Hydroxychloroquine Market (2025–2032): Spherical Insights Analysis
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The hydroxychloroquine is classified as an aminoquinoline derivative chemotherapeutic agent that functions as an antimalarial and antirheumatic agent based on its capacity to influence and decrease inflammation. In the hydroxychloroquine is used to treat various autoimmune diseases due to its efficacy and affordability. The drug is also used to treat malaria. Other less common inflammatory disorders for which hydroxychloroquine is used could be regarded as expanding market opportunities for hydroxychloroquine. The innovations in the global hydroxychloroquine market involve formulations that improve bioavailability and safety profiles of the drug, as well as AI-based manufacturing approaches that minimize costs while ensuring API quality. Future opportunities in the global hydroxychloroquine market involve repurposing the drug to treat cancer, heart disease, and fibrosis. In addition, there is an increase in healthcare investments in developing markets as well as continued demand for generics in terms of cost-effectiveness.
The National Pharmaceutical Pricing Authority regulated pricing and coordinated hydroxychloroquine supply in India during April 2020, ensuring affordability and availability, thereby supporting domestic stability and reinforcing supply reliability in the global hydroxychloroquine market.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Hydroxychloroquine Market .
Hydroxychloroquine Market Size & Statistics
- The Market Size for Hydroxychloroquine Market Was Estimated to be worth USD 1923.5 million in 2024.
- The Market Size is Going to Expand at a CAGR of 8.53% between 2025 and 2035.
- The Global Hydroxychloroquine Market Size is anticipated to reach USD 4734.3 million by 2035.
- North America is estimated to generate the highest demand during the forecast period in the Global Hydroxychloroquine Market.
- Asia Pacific is projected to grow the fastest during the forecast period in The Global Hydroxychloroquine Market.
Market Segmentation
Global Hydroxychloroquine Market Size, Share, By Drug Class (Antimalarial, Anti-rheumatic Hydroxychloroquine Drug, Lupus Suppressant Hydroxychloroquine Drug, Hydroxychloroquine Drug, Anti-COVID 19 Hydroxychloroquine Drug), By Standards Grade (USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, Others), By Strength (200 mg, 400 mg, 800 mg), By End User (Hospitals, Specialty Clinics, Homecare, Others), And By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Region al growth and demand
Asia‑Pacific is expected to grow the fastest during the forecast period in the Hydroxychloroquine Market. It is fuelled by increasing investments in healthcare in India and China, as well as an increase in malaria and autoimmune disease incidence. The area also has an advantage in terms of the generic formulation base, the API base, as well as the government initiatives. Further, the better access to healthcare services and an increase in exports will also contribute to the growth.
North America is anticipated to generate the highest demand during the forecast period in the Hydroxychloroquine Market. It is caused by the high burden of autoimmune disorders, including lupus and rheumatoid arthritis, across the United States and Canada. Robust healthcare expenditure, strong insurance coverage, established treatment protocols, and the presence of leading pharmaceutical companies further drive consistent drug utilization and market demand growth across the region.
Ready to lead the Global Hydroxychloroquine Market
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 trends in the Hydroxychloroquine Market
- Rising Demand for Autoimmune Disease Treatment
- Declining Role in Malaria Treatment
- Expansion of Generic Drug Manufacturing
- Government Stockpiling and Strategic Reserves
- Regulatory Scrutiny and Safety Monitoring
- Growth in Asia-Pacific Demand
- Increased Focus on API Supply Chain Localization
- Integration into Combination Therapies Research
- Pricing Pressure Due to Generic Competition
- Strengthening Pharmaceutical Export Markets
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Hydroxychloroquine Market .
1.Rising Demand for Autoimmune Disease Treatment
The continued demand for hydroxychloroquine is being driven by the rising incidence of inflammatory diseases including lupus and rheumatoid arthritis. Prescription volumes are being strengthened by long-term treatment protocols and chronic illness management, especially in developed healthcare markets with well-established diagnostic and therapeutic infrastructure.
2.Declining Role in Malaria Treatment
It is due to widespread resistance and the use of combination therapies based on artemisinin the market is seeing a slow decrease in demand related to malaria. Nonetheless, hydroxychloroquine is still useful in areas that are sensitive to chloroquine, sustaining baseline demand in some developing nations.
3.Expansion of Generic Drug Manufacturing
The generic producers, especially those in China and India, control the majority of the hydroxychloroquine market. Strong API skills, export-focused tactics, and cost-effective production are boosting global supply, increasing affordability, and escalating price rivalry in international marketplaces.
4.Government Stockpiling and Strategic Reserves
In order to meet emergency medical needs, governments are increasingly keeping strategic stockpiles of necessary medications, such as hydroxychloroquine. The significance of supply security has been brought to light by pandemic-driven procurement practices, impacting long-term demand forecasting and inventory management tactics worldwide.
5.Regulatory Scrutiny and Safety Monitoring
The safety profile of hydroxychloroquine has come under more scrutiny due to enhanced regulatory control after COVID-19. Pharmacovigilance is emphasized by authorities like the U.S. Food and Drug Administration, which uses more stringent clinical usage criteria to influence prescribing practices and market demand.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Hydroxychloroquine Market .
Top 25 Companies Leading the Hydroxychloroquine Market
- Sanofi
- Novartis
- Teva Pharmaceutical Industries
- Viatris (Mylan)
- Sun Pharmaceutical Industries
- Dr. Reddy’s Laboratories
- Lupin
- Zydus Lifesciences
- Cipla
- Laurus Labs
- Ipca Laboratories
- Amneal Pharmaceuticals
- Hikma Pharmaceuticals
- Accord Healthcare
- Aurobindo Pharma
- Jubilant Pharmova
- Advanz Pharma
- Hetero Labs
- Mangalam Drugs & Organics
- Cadila Pharmaceuticals
- Prasco
- Covis Pharma
- Cardinal Health
- McKesson Corporation
- Aphena Pharma SolutionsH
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Hydroxychloroquine Market .
1. Sanofi
Headquarters: Paris, France
The company, Sanofi, was founded in 1973 and has over 90,000 employees worldwide. The company generated estimated revenues of over 45 billion USD in 2025. Sanofi produces hydroxychloroquine under existing brands, thus aiding in the treatment of malaria and autoimmune diseases, thereby further cementing the strong standing of the company in the global hydroxychloroquine market.
2. Novartis
Headquarters: Basel, Switzerland
The Novartis, was founded in 1996 and currently having over 100,000 employees worldwide, has reported an estimated revenue of USD 48 billion for 2025. Novartis, through its generics segment, supports hydroxychloroquine for malaria and autoimmune diseases treatment, thereby adding to its diversification and maintaining stable hydroxychloroquine market conditions.
3. Teva Pharmaceutical Industries
Headquarters: Tel Aviv, Israel
The Teva Pharmaceutical Industries, established in 1901, has approximately 37,000 employees worldwide. The company’s estimated revenue was around USD 16 billion in 2025. Teva is a manufacturer of generic hydroxychloroquine, which aids in the treatment of autoimmune diseases as well as malaria. This further adds to the company’s generics segment in the global hydroxychloroquine industry.
4. Viatris (Mylan)
Headquarters: Canonsburg, Pennsylvania, United States
The Viatris (Mylan), was founded in 2020, has approximately 37,000 employees worldwide. The company has reported revenues of about USD 15 billion in 2025. The company produces generic hydroxychloroquine and helps ensure that malaria and autoimmune diseases can be treated at an affordable cost, thereby maintaining supply chain stability for hydroxychloroquine.
5. Sun Pharmaceutical Industries
Headquarters: Mumbai, India
The Sun Pharmaceutical Industries, was established in 1983, has over 38,000 employees worldwide. The company generated estimated revenues of over USD 6 billion in 2025. Sun Pharma produces hydroxychloroquine formulations used to treat malaria and other autoimmune diseases. This is done by utilizing its robust API capabilities and distribution networks, thereby strengthening its position as a competitor in the global hydroxychloroquine market.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Hydroxychloroquine Market .
Are you ready to discover more about the Hydroxychloroquine Market?
The report provides an in-depth analysis of the leading companies operating in the global Hydroxychloroquine Market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
1.Sanofi
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
2.Novartis
3.Teva Pharmaceutical Industries
4.Viatris (Mylan)
5.Sun Pharmaceutical Industries
6.Dr. Reddy’s Laboratories
7.Lupin
8.Zydus Lifesciences
9.Cipla
10.Others.
Other Industry Reports :
Anti-Infective Vaccines Development Market Report Till 2035
Top 25 Companies in Anti Icing Coating Market
Top 25 Companies in Antihistamine Drugs Market
Top 30 Companies in HPL Fire-Resistant Board Market
Top 30 Companies in Interventional Pulmonology Market
Conclusion
The global hydroxychloroquine market is expected to continue its growth trajectory and is projected to register an increase from USD 1,923.5 million in 2024 to USD 4,734.3 million in 2035, registering a compound annual growth rate of 8.53%. The hydroxychloroquine market is mainly influenced by factors such as an increase in autoimmune diseases, high prevalence of malaria in tropical regions, and easy availability of cost-effective generics. North America is currently the largest contributor to the hydroxychloroquine market, followed by other regions. On the other hand, the Asia-Pacific region is forecasted to register the highest growth rate due to its high manufacturing and healthcare infrastructure. The government is playing a vital role in maintaining the supply chain and market growth through its interventions. Moreover, hydroxychloroquine is being increasingly used for repurposing in cancer and other chronic diseases. The hydroxychloroquine market is highly competitive due to the presence of major global and generic pharmaceutical companies. The market is registering a stable growth rate and is likely to sustain for a longer period.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?